Genzyme Corporation filed 25 H-1B LCAs in FY2023. Average salary: $150k.
In FY FY2023, Genzyme Corporation filed 25 H-1B petitions with an average salary of $150k. Top positions include Head of Global Immunology Franchise (8%), Senior Manager, Omnichannel Analytics (8%), Dir., Global Insights, Forecasting & Analytics - Hemophilia (4%). Filings were concentrated in Massachusetts (88%), New Jersey (8%), Pennsylvania (4%). The certification rate was 100%. Salaries ranged from $87k to $338k.
| Percentile | Salary |
|---|---|
| 10th | $103k |
| 25th | $116k |
| 50th (Median) | $139k |
| 75th | $154k |
| 90th | $197k |
Based on 25 salary records. Range: $87k – $338k.
36% of filings offer salaries above the prevailing wage, with an average premium of 12.9%. The average prevailing wage is $136k (based on 25 filings).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 10 days. Based on 25 filings.
44% of filings are for new positions, while 4% are for continued employment (25 filings).
Average contract duration: 36 months (median: 36 months), based on 25 filings.
| Visa Class | Filings |
|---|---|
| H-1B | 24 |
| E-3 AUSTRALIAN | 1 |
| Education Level | Filings |
|---|---|
| Not Specified | 25 |
| Job Title | Filings |
|---|---|
| Head of Global Immunology Franchise | 2 |
| Senior Manager, Omnichannel Analytics | 2 |
| Dir., Global Insights, Forecasting & Analytics - Hemophilia | 1 |
| Senior Medical Science Liaison | 1 |
| Safety Governance Expert | 1 |
| Medical Evidence Generation Lead | 1 |
| Associate Director, PSS, Analytics and Reporting, RBD | 1 |
| Sr. Scientist - Drug Metabolism and Pharmacokinetics | 1 |
| Manufacturing Supervisor | 1 |
| Senior Manager, Analytics - Rare Disease | 1 |
Genzyme Corporation filed 25 H-1B Labor Condition Applications (LCAs) in FY2023.
The average H-1B salary at Genzyme Corporation in FY2023 was $150k.
The top H-1B job titles sponsored by Genzyme Corporation in FY2023 include Head of Global Immunology Franchise, Senior Manager, Omnichannel Analytics, Dir., Global Insights, Forecasting & Analytics - Hemophilia.